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Abstract 
To date four isoforms of triadins have been identified in rat skeletal muscle. While the function of 
the 95 kDa isoform in excitation-contraction coupling has been studied in detail, the role of the 
32 kDa isoform (Trisk 32) remains elusive. Here Trisk 32 overexpression was carried out by stable 
transfection in L6.G8 myoblasts. Co-localization of Trisk 32 and IP3 receptors (IP3R) was 
demonstrated by immunocytochemistry and their association was shown by co-
immunoprecipitation. Functional effects of Trisk 32 on IP3-mediated Ca2+ release were assessed by 
measuring changes in [Ca2+]i following the stimulation by bradykinin or vasopressin. The 
amplitude of the Ca2+ transients evoked by 20 µM bradykinin was significantly higher in Trisk 32-
overexpressing (p<0.01; 426±84 nM, n=27) as compared to control cells (76±12 nM, n=23). The 
difference remained significant (p<0.02; 217±41 nM, n=21 and 97±29 nM, n=31, respectively) in 
the absence of extracellular Ca2+. Similar observations were made when 0.1 µM vasopressin was 
used to initiate Ca2+ release. Possible involvement of the ryanodine receptors (RyR) in these 
processes was excluded, after functional and biochemical experiments. Furthermore, Trisk 32 
overexpression had no effect on store-operated Ca2+-entry, despite a decrease in the expression of 
STIM1. These results suggest that neither the increased activity of RyR, nor the amplification of 
SOCE are responsible for the differences observed in bradykinin- or vasopressin-evoked Ca2+ 
transients, rather, they were due to the enhanced activity of IP3R. Thus Trisk 32 not only co-
localizes with, but directly contributes to the regulation of Ca2+ release via IP3R. 
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Abbreviations 
 
The abbreviations used are: [Ca2+]e, extracellular calcium concentration; [Ca2+]i, 
intracellular calcium concentration; AM, acetoxy-
methylester; AVP, arginine-vasopressin; CICR, Ca2+-
induced Ca2+ release; DAG, diacylglycerol; DHPR, 
dihydropyridine receptor; ER, endoplasmic reticulum; 
IP3, inositol 1,4,5-trisphosphate; IP3R, inositol 1,4,5-
trisphosphate receptor; IP3R-III, IP3R type III; PIP2, 
phosphatidylinositol 4,5 bisphosphate; PLC, 
phospholipase C; RyR, ryanodine receptor; SERCA, 
sarco- endoplasmic reticulum calcium ATPase; SOCE, 
store-operated Ca2+-entry; SR, sarcoplasmic reticulum; 
STIM1, stromal interaction molecule 1; TG, 
thapsigargin; Trisk 32, 32 kDa isoform of skeletal 
muscle triadin; TRPC, transient receptor potential 
canonical; 
 
Introduction 
 
In mammalian cells changes in intracellular calcium concentration 
([Ca2+]i) control a wide variety of functions, including division, secretion, motility 
and contractility. To precisely regulate these changes in [Ca2+]i highly organized 
structures are present in adult skeletal muscle fibers. The depolarization of the 
plasma membrane initiates a conformational change in the voltage sensors, the 
dihydropyridine receptors (DHPRs), of the surface membrane which in turn 
activate the ryanodine receptors (RyRs). Through these channels Ca2+ is released 
from the sarcoplasmic reticulum (SR), the intracellular Ca2+ store (for review see 
e.g. [11, 26]). 
In the early stages of skeletal muscle differentiation - in myoblasts - this 
complex structure, however, is not at all functional, rather, inositol 1,4,5-
trisphosphate receptors (IP3Rs) have a significant role in the Ca2+ release from the 
endoplasmic reticulum (ER) (see e.g. [7]). In response to different external stimuli 
(as the activation of bradykinin or vasopressin receptors), phospholipase C (PLC) 
hydrolyses phosphatidylinositol 4,5 bisphosphate (PIP2) in the plasma membrane 
to produce IP3 and diacylglycerol (DAG). While DAG activates protein kinase C 
(PKC), IP3 binds to the Ca2+ release channel of the ER. Molecular and 
physiological properties of the IP3R closely resemble those of the RyR [10]. It has 
at least four known isotypes, which are all present in rodent skeletal muscle 
together with the basic molecular machinery for a functioning IP3 messenger 
system [22]. The binding of IP3 to its receptor activates Ca2+ release from the store 
to increase [Ca2+]i [34].  
RyRs have been shown to interact with a number of different proteins 
present in the triadic junction including, among others, calsequestrin, junctate, 
junctin, JP45, mitsugumins, and triadin (for review see [31]). From this group of 
SR membrane proteins triadin was first to be identified in rabbit skeletal muscle in 
1990 [5, 16] as a 95 kDa glycoprotein specifically located in the triads, and was 
later proved to decrease the extent of Ca2+ release via RyRs [9, 24]. Since then 
several isoforms have been identified both in skeletal and cardiac muscle [13, 14, 
19, 33]. 
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The 32 kDa isoform of triadin (Trisk 32), smallest skeletal muscle triadin 
[33], is identical to CT1, the major cardiac triadin [17], and is the only triadin 
isoform expressed in both muscles. It derives from an alternative splicing after the 
eight first exons of the triadin gene and possesses a unique C-terminal end. 
Interestingly though, the expression of this isoform precedes that of RyR during 
muscle differentiation [ZZZ]. This unique timing of its expression raises several 
questions. First, why would a member of a family of proteins that were originally 
described as regulating RyR be expressed at times when RyR is not yet present 
and, second, could there be an alternative function of Trisk 32 in skeletal muscle? 
Despite the structural and functional similarity to RyR, proteins that 
specifically interact with and modify the function of IP3R have not been 
characterized. In skeletal muscle, Trisk 32 has been shown to be localized within 
the longitudinal SR, co-localized with IP3R and the mitochondria, and to be 
associated with IP3R [33]. The existence of a non-triadic Ca2+-release complex 
centered around IP3R and involving Trisk 32 has been proposed, and in this 
context, the function of Trisk 32 could be the regulation of the Ca2+ releases via 
IP3R [33]. 
To test this hypothesis Trisk 32 has been overexpressed in a rat skeletal 
muscle cell line that contains endogenously the components of the IP3 signaling 
cascade. The protein was found to co-localize and co-immunoprecipitate with 
IP3R in transfected cells. The expression of this triadin isoform greatly increased 
Ca2+ release from the ER following the stimulation of the cells by either 
bradykinin or vasopressin strengthening the idea that Trisk 32 is functionally 
associated with this calcium release channel. 
 
Experimental procedures 
 
Cell cultures and transfection 
L6.G8 rat skeletal muscle myoblasts were obtained from European 
Collection of Cell Cultures (ECACC) and were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM; Sigma, Budapest, Hungary) supplemented with 10% 
fetal bovine serum (FBS), 2 mM glutamine, 50 U/ml penicillin, and 50 µg/ml 
streptomycin and were incubated at 37 ºC in a humidified incubator with 5% CO2 
and 95% O2 (according to the instructions of the supplier). Cells were seeded at a 
density of 1000-2000 cells/cm2 and were cultured for 4 days before the 
experiments. 
Full length coding sequence of rat Trisk 32 (accession number AJ812276) 
was ligated into the EcoR1 restriction site of pcDNA 3.1 (Invitrogen, ZZZ) 
expression vector [33]. Stable transfection was performed in Opti-MEM reduced 
serum content medium using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, 
CA, USA) for 2.5 h at 37 ºC. Cells were allowed to express the transfected genes 
for 48 h in growth medium then were selected in DMEM containing 1 mg/ml 
geneticin. After 14-15 days, single colonies were isolated and experiments were 
carried out on those separated clones (ZZZ that particular clone) of Trisk 32 
transfected cells that showed the highest Trisk 32 expression. To obtain a control 
for the transfection, cells were transfected by empty pcDNA 3.1 vector using the 
same protocol, and experiments were carried out on pools of transfected cells. The 
transfection with the empty or Trisk 32 containing vector did not affect cell 
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viability but significantly reduced, to the same extent, the proliferation of the 
myoblasts (see Online Resource 2A and 2B, respectively) 
The efficiency of Trisk 32 overexpression was monitored at protein level 
by immunostaining and Western-blot using a specific anti-Trisk 32 antibody 
corresponding to the C-terminal end of the peptide [33]. Functional experiments 
were carried out on myoblasts. 
 
Immunostaining 
Cultured cells were washed with ice-cold phosphate-buffered saline (PBS; 
0.02 M NaH2PO4, 0.1 M NaCl), fixed with 4% paraformaldehyde or 100% 
methanol at -20°C for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 
10 min, and blocked with 1% BSA diluted in PBS (blocking solution) for 30 min 
at room temperature. The cells were then incubated overnight at 4 ºC with the 
anti-Trisk 32 primary antibody (dilution was 1:500 in blocking solution) produced 
in rabbit or in Guinea pig [33]; the anti-IP3-receptor type I, II, III primary 
antibody (dilution was 1:50 in blocking solution), corresponding to C-terminal 
amino acid residues 2402-2701 of IP3R, produced in rabbit (Santa-Cruz 
Biotechnology Inc., Heidelberg, Germany); the anti-B2 bradykinin receptor 
primary antibody (dilution was 1:100 in blocking solution), corresponding to the 
C-terminal region of the protein, produced in rabbit (Sigma); the anti-arginine-
vasopressin receptor V1a antibody (dilution was 1:50 in blocking solution), 
corresponding to C-terminal amino acid residues 349-418 of the protein, produced 
in rabbit (Santa-Cruz). The secondary antibody, anti-rabbit or anti-guinea pig IgG, 
labeled with fluorescein or Cy3 was incubated for 1 h at room temperature. The 
nuclei were stained with DAPI in Vectashield mounting medium (Vector 
Laboratories, Burlingame, CA, USA). Images were acquired with LSM 510 
META confocal microscope (Zeiss, Oberkochen, Germany). (For negative 
controls for immunocytochemical stainings see Online Resource 1C.) 
 
RT-PCR analysis 
For RT-PCR analysis, total RNA was isolated from myoblasts using Trizol 
reagent (Invitrogen). The volume and purity of the isolated RNA were verified 
with Nano-Drop 1000 Spectrophotometer (Wilmington, Delaware, USA). The 
assay mixture (20 µl) for reverse transcriptase reaction (Omniscript, Qiagen) 
contained 500 ng RNA, 0.25 µl RNase inhibitor, 0.25 µl oligo (dT), 2 µl dNTP 
(200 µM), 1 µl M-MLV RT in 1×RT buffer. Amplifications of specific cDNA 
sequences were performed with specific primers (Integrated DNA Technologies, 
Coralville, IA, USA) that were designed based on published rat Trisk 32 
nucleotide sequences (GenBank Accession No.: AJ812276, forward primer: 5’-
TGAACGATGTTGTGGAGGAA-3’, reverse primer: 5’-
CTCTGGCTTTCGGTGTTG-3’). PCR reactions were allowed to proceed in a 
final volume of 50 µl (containing 2 µl forward and reverse primers, 1 µl dNTP 
(200 µM), and 0,5 µl Promega GoTaq® DNA polymerase in 1×reaction buffer) in 
a Bio-Rad C1000 Thermal Cycler (Bio-Rad, Budapest, Hungary) with the 
following settings: 2 min at 95 C for initial denaturation followed by repeated 
cycles of denaturation at 94 C for 1 min, primer annealing for 60 s at an optimized 
temperature, and extension at 72 C for 90 s. After the final cycle, further 
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extension was allowed to proceed for another 10 min at 72 C. PCR products were 
analyzed using EZ-Vision Three (Amresco, Solon, USA) on agarose gel. 
 
Preparation of cell extracts 
Cells in cultures were washed with ice-cold PBS, harvested in 
homogenization buffer (20 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1 mM 4-(2-
aminoethyl) benzenesulphonyl fluoride, 20 µm leupeptin; all from Sigma) and 
disrupted by sonication on ice. Protein content of the samples was measured by a 
modified bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA) 
using BSA as a standard. The rat light SR vesicle used as positive control in 
Western-blot experiments was a gift from I. Jona [1]. 
 
Western-blot analysis 
Total cell lysates were examined by Western-blot analysis. Samples for 
SDS–PAGE were prepared by the addition of 1/5 volume of 5-fold concentrated 
electrophoresis sample buffer (310 mM Tris–HCl, pH 6.8; 10 % SDS, 50 % 
glycerol, 100 mM DTT, 0.01 % bromophenol blue) to cell lysates and boiled for 
5 min at 80 °C. About 100 µg of protein was separated by 10% SDS-PAGE gel 
for immunological detection of Trisk 32, TRPC1, STIM1, RyR, IP3R-I, II, and III. 
Proteins were transferred electrophoretically to nitrocellulose membranes (Bio-
Rad, Budapest, Hungary). After blocking with 5% non-fat dry milk in PBS, 
membranes were incubated with the following primary antibodies overnight at 
4 ºC: anti-Trisk 32 antibody (dilution: 1:5000), anti-TRPC1 antibody (dilution: 
1:200), anti-STIM1 antibody (dilution: 1:500), anti-IP3R type III antibody 
(dilution: 1:200) corresponding to amino acid residues 22-230 of human IP3R-III, 
produced in mouse (BD Transduction Laboratories, Le Pont de Claix-Cedex, 
France), anti-RyR antibody (dilution: 1:100) corresponding to whole protein of 
pig RyR, produced in rabbit [18], anti-IP3R type I antibody (dilution: 1:200) 
corresponding to cytoplasmic amino acid residues 1894-1973 of human IP3R-I, 
produced in rabbit (Santa-Cruz), and anti-IP3R type II antibody (dilution: 1:200) 
corresponding to C-terminus of human IP3R-II, produced in goat (Santa-Cruz). 
After washing three times for 10 min with PBST (PBS supplemented with 0.1% 
Tween 20), membranes were incubated with a secondary antibody, peroxidase-
conjugated goat anti-rabbit or anti-mouse, or rabbit anti-goat IgG (Bio-Rad) in 
1:1000 dilution in PBS containing 5% non-fat dry milk for 1 h. Signals were 
detected by enhanced chemiluminescence (ECL) reaction (Pierce). 
 
Whole cell calcium measurement 
Changes in [Ca2+]i were measured using the calcium sensitive fluorescent 
dye Fura-2 as reported earlier [27]. Myoblasts were placed on a coverslip and 
incubated with Fura-2 AM (acetoxy-methylester; 10 µM) for 1 h (37 ºC, 5% CO2) 
in DMEM supplemented with 10% FBS and neostigmin to inhibit acethylcholine-
esterase. Thereafter cells were equilibrated in normal Tyrode’s solution (in mM: 
137 NaCl, 5.4 KCl, 0.5 MgCl2, 1.8 CaCl2, 11.8 HEPES, 1 g/l glucose, pH 7.4, all 
from Sigma) for 30 min at room temperature. Coverslips with the Fura-2 AM 
loaded cells were then placed on the stage of an inverted fluorescent microscope 
(Diaphot; Nikon, Tokyo, Japan). Measurements were performed in normal or 
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calcium-free Tyrode’s solution. To obtain a calcium-free Tyrode’s solution no 
CaCl2 was added in the presence of 5 mM EGTA (Sigma). Bradykinin (Sigma) 
was used at a final concentration of 20 µM in normal and calcium-free Tyrode’s 
solution. 0.1 µM arginine-vasopressin (AVP; from Sigma) was used in calcium-
free Tyrode’s solution. The SERCA inhibitor thapsigargin (Sigma) was used at a 
final concentration of 2 µM in calcium-free Tyrode’s solution. The IP3R agonist 
thimerosal (Sigma) was used at a final concentration of 50 µM in calcium-free 
Tyrode’s solution. Caffeine (Sigma), and ryanodine (Sigma) were used in 30 mM 
and 10 µM concentrations respectively, in normal Tyrode’s solution. 
Xestospongin C (Merck, Budapest, Hungary) was used as a pre-treatment in 
50 µM concentration in normal Tyrode’s solution for 1 h in room temperature. 
Cells were continuously washed by Tyrode’s solution using a background 
perfusion system. Test solutions were directly applied to the cells through a 
perfusion capillary tube (Perfusion Pencil™; AutoMate Scientific, San Francisco, 
CA, USA) with an internal diameter of 250 µm at a 0.35 ml/min rate, using a local 
perfusion system (Valve Bank™ 8 version 2.0, AutoMate Scientific). All 
measurements were performed at room temperature. Excitation wavelength was 
alternated between 340 and 380 nm by a dual wavelength monochromator 
(Deltascan, Photon Technology International, New Brunswick, NJ, USA), while 
the emission was monitored at 510 nm using a photomultiplier. [Ca2+]i was 
calculated from the ratio of fluorescence intensities (R = F340/F380) using an in 
vivo calibration (Rmin = 0.2045, Rmax = 8.315, Kd β = 1183) as described [12]. 
Data were statistically analyzed by Student’s t-test. The data are presented as 
mean ±SEM. 
 
Confocal measurements 
Calcium transients were also monitored with the LSM 510 META 
confocal laser scanning microscope (Zeiss, Oberkochen, Germany) as described 
earlier [28]. L6 myoblasts were incubated with 10 µM Fluo-4-AM for 1 h at 
37 ºC. Calcium imaging was performed in calcium-free Tyrode’s solution. Line-
scan images were used to monitor the fluorescence intensity, and were recorded at 
24 ms per line and 512 pixels per line using a 63× water immersion objective. 
Fluo-4 was excited with an argon ion laser. Cells were continuously washed by 
Ca2+-free Tyrode’s solution using a background perfusion system. 0.1 µM AVP 
solution dissolved in Ca2+-free Tyrode’s solution was directly applied to the cells 
using a local perfusion system. All measurements were performed at room 
temperature. Images were analyzed by using an automatic event detection 
program [28], developed in the Department of Physiology, University of 
Debrecen, Hungary. Fluorescence of the images (F) was normalized to baseline 
fluorescence (F0) and amplitudes of the transients were determined as ∆F/F0. The 
data are presented as mean ±SEM. 
 
Results 
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Cell culturing and transfection 
Trisk 32 protein synthesis was amplified using a pcDNA3.1 plasmid-
vector system. In order to select the clone showing the most significant Trisk 32 
expression from the plasmid (referred to as Trisk 32 or T32 in the figures hereon), 
immunocytochemistry, RT-PCR and Western-blot experiments were performed 
and the clone showing the highest expression of the protein (Fig. 1A right panel, 
Fig. 1B and Fig. 1C) was used for further experiments. The endogenous mRNA 
expression of Trisk 32 was slightly detectable in control cells (Fig. 1B). On the 
other hand the endogenous protein expression of Trisk 32 in control cells or in 
cells transfected by the pcDNA 3.1 vector alone, could not be shown with 
Western-blot (Fig. 1A left panel and Fig. 1C). Note that the protein is detected as 
a double band on the Western-blot as described earlier [ZZZ]. 
 
Effect of Trisk 32 overexpression on the function of IP3 receptors 
The presence of IP3R-III (Online Resource 1E, Lanes 1 and 2), I and II 
(Online Resource 1F) was shown by Western-blot both in control and Trisk 32-
overexpressing myoblasts. The amount of IP3R-I and III was similar in control 
and transfected cells, while IP3R-II was undetectable. Based on these 
measurements we concluded that the major isoform in L6.G8 myoblasts was 
IP3R-III. The presence of Trisk 32 protein could only be shown clearly in 
Trisk 32-overexpressing cells (Online Resource 1E, Lane 2). Co-localization of 
Trisk 32 and IP3R was confirmed by immunocytochemistry, using double-
fluorescent labeling of the two proteins (Online Resource 1D). To prove that they 
are not only partially co-localized but also associated, co-immunoprecipitation 
experiments were performed (Online Resource 1E, Lanes 3 and 4). 
ZZZ Supp info-ba After immunoprecipitation with anti-Trisk 32 antibody, 
the immune complexes were analyzed in Western-blot with anti-IP3R-III and anti-
Trisk 32 antibodies. In control cells neither Trisk 32, nor the IP3R were present in 
the immunoprecipitated samples. In the samples of Trisk 32-overexpressing cells 
the immunoprecipitation of Trisk 32 leads to the co-immunoprecipitation with 
IP3R-III (Online Resource 1E, Lane 4). ZZZ 
To show the functional effects of Trisk 32 overexpression on the 
regulation of IP3R and the Ca2+ homeostasis of the cells, line-scan images were 
taken by confocal microscopy in the absence of extracellular calcium 
concentration ([Ca2+]e). The IP3 pathway was stimulated by the local application 
of 0.1 µM AVP (the presence of V1a AVP receptors is shown in Online Resource 
1B). The amplitude of the Ca2+ transients evoked by AVP (Fig. 2) were 
significantly higher (p<0.01) in Trisk 32-overexpressing cells (3.25±0.23, n=34, 
expressed as F/F0; Fig. 2C) as compared to control (1.45±0.17, n=21; Fig. 2A) and 
empty pcDNA3.1 vector transfected (2.02±0.23, n=25; Fig. 2B) myoblasts. The 
amplitude of the transients did not differ significantly (p>0.05) between control 
and empty pcDNA 3.1 vector transfected cells (Fig. 2D). From these experiments 
and from those presented below (see Fig. 4), as well as from our earlier results [9] 
we concluded that the transfection with the empty vector does not affect the IP3 
pathway. To examine the effect of the inhibition of IP3Rs, Trisk 32 
overexpressing cells were pre-treated with 50 µM Xestospongin C for 1 h, and 
then fluorescent [Ca2+]i measurements were performed with the local application 
of 0.1 µM AVP in the absence of [Ca2+]e. The application of the inhibitor 
significantly decreased the amplitudes of the AVP-induced Ca2+ transients 
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compared to the untreated Trisk 32 overexpressing cells (106±31 nM, n=9 and 
179±14 nM, n=9, respectively, p<0.05, Fig. 2E). 
ZZZ Representative records of the measurements are shown in Fig. 3A. In 
this case 20 µM bradykinin was used to activate the IP3 pathway in control and 
transfected myoblasts (the presence of B2 bradykinin receptors on these cells is 
shown in Online Resource 1A). In some of the experiments 1.8 mM [Ca2+]e was 
applied to achieve a more physiological condition, in other experiments 0 mM 
[Ca2+]e was used to study clearly the Ca2+ released from the SR without the entry 
of extracellular Ca2+. In normal Tyrode’s solution with 1.8 mM [Ca2+]e, 
significant difference could be observed between control and transfected cells 
both in the amplitude (76±12 nM, n=23 and 426±84 nM, n=27 respectively, 
p<0.01, Fig. 3B) and in the maximal rate of rise (3.3±1.1 nM/s and 35.1±9.6 nM/s 
respectively, p<0.01, Fig. 3C) of the bradykinin-evoked Ca2+ transients. In the 
absence of extracellular Ca2+ the significant difference between the two cell types 
remained in the amplitude (97±29 nM, n=31 and 217±41 nM, n=21 respectively, 
p<0.02, Fig. 3B), however the difference in the maximal rate of rise of the 
transients did not prove to be significant (8.7±3.5 nM/s and 18.9±4.5 nM/s, 
respectively, p=0.08, Fig. 3C). It should be noted that these differences were not 
due to an increase in the resting [Ca2+]i ([Ca2+]rest) since it was essentially identical 
in control and Trisk 32 overexpressing cells; (73±2 nM, n=31 and 74±2 nM, n=21 
respectively, p>0.9) in the absence of [Ca2+]e. Note also that the amplitude of the 
bradykinin- and the AVP-evoked Ca2+ transients in the absence of [Ca2+]e was 
similar in Trisk 32 overexpressing cells (217±41 nM, n=21 and 179±14 nM, n=9, 
respectively, p>0.5). 
The observed augmentation of agonist-evoked Ca2+ transients observed in 
Trisk 32-overexpressing cells could be explained either by altered IP3R function –
 increased channel conductance or increased IP3 sensitivity – or by modified 
SOCE that accompanied store depletion. To explore the possibility that the 
increased conductance of IP3R would be the explanation for the increased 
elevation in [Ca2+]i following agonist application, IP3Rs were directly activated by 
the addition of 50 µM thimerosal to the culture medium. The drug induced a slow 
rise in [Ca2+]i that appeared with a considerable latency in both control, mock-
transfected, and Trisk 32-overexpressing cells (Fig. 4A). Pooled data proved that 
these calcium transients are essentially identical (p>0.8) both in their amplitude 
(84.2±5.4, 82.7±7.4, and 83.1±4.8 nM; Fig. 4B) and in their rate of rise 
(0.26±0.04, 0.25±0.01, and 0.27±0.04 nM/s in control, in empty pcDNA3.1 
vector-transfected, and in Trisk 32-overexpressing cells, respectively; Fig. 4C). 
Effect of Trisk 32 overexpression on SOCE 
To examine whether the overexpression of Trisk 32 alters the SOCE 
mechanism of the myoblasts, the expression level of the key molecules of SOCE 
was tested by Western-blot. The expression of STIM1 (Fig. 5A) decreased 
significantly, to 48±7% of the control in the transfected myoblasts (Fig. 5C), 
while the expression of TRPC1 did not change (Fig. 5B and C). 
Measurements of intracellular calcium concentration were performed to 
assess the functional consequences of Trisk 32 overexpression and the decreased 
expression of STIM1 on SOCE. Internal calcium-stores were thus emptied by the 
application of 2 µM thapsigargin (TG) in the absence of [Ca2+]e  The changes in 
[Ca2+]i evoked by re-establishing the normal 1.8 mM extracellular calcium 
concentration ([Ca2+]e) were then measured in control (Fig. 5D upper panel) and 
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in Trisk 32-overexpressing L6 myoblasts (Fig. 5D bottom panel) [4]. Neither the 
amplitude (105±18 nM, n=22 and 126±22 nM, n=21, respectively p>0.4, Fig. 5E), 
nor the maximal rate of rise (0.8±0.2 nM/s and 1.4±0.4 nM/s, respectively p>0.2, 
Fig. 5F) of SOCE differed significantly in the two cell types. 
To assess whether a change in ER Ca2+ content could underlie some of the 
observed alterations, the parameters of the thapsigargin-evoked Ca2+ transients 
were compared for control and Trisk 32 overexpressing cells. Neither the integral 
(27.0±3.1 mM·s, n=7 and 28.7±4.5 mM·s, n=15, respectively, p>0.8) nor the 
amplitude (146±19 nM, and 199±25 nM, respectively, p>0.1) of these signals 
were altered significantly by the transfection (Fig. 5G). 
 
Effect of Trisk 32 overexpression on the function of RyRs 
To exclude the possible involvement of RyR in the changes described above, Ca2+ 
release via ryanodine receptors was examined by applying 30 mM caffeine on 
control and Trisk 32-overexpressing myoblasts (Fig. 6A). Only two thirds of the 
cells responded to caffeine (19 from 31, and 20 from 30 in control and Trisk 32 
overexpressing cells, respectively) and the expression of RyR could not be shown 
by Western-blot (Fig. 6C), which means that only a minimal amount of the 
receptor was present and functional in these cells. The amplitude of the Ca2+ 
transients – where such transients were observed at all – did not differ 
significantly (61±7 nM, n=19 and 53±6 nM, n=20 respectively, p>0.3; Fig. 6B). 
To examine the contribution of Ca2+-induced Ca2+ release via RyRs in the 
bradykinin-evoked Ca2+ transients, RyRs were blocked by 10 µM ryanodine then 
20 µM bradykinin was applied to activate the IP3 pathway in Trisk 32-
overexpressing cells. Although the amplitude of the transients were lower in the 
presence of ryanodine, this difference did not prove to be significant if compared 
to those obtained in the absence of the drug (275±26 nM, n=21 and 426±84 nM, 
n=27, respectively, p>0.1; Fig. 6D). Similarly when RyRs were blocked by 10 µM 
ryanodine then the IP3 pathway was activated by 0.1 µM AVP in the absence of 
[Ca2+]e in Trisk 32-overexpressing cells, the difference in the amplitude of the 
transients was not significant (179±14 nM, n=9 in the absence and 132±23 nM, 
n=9 in the presence of the drug,  p>0.1). 
 
Discussion 
 
Triadin was described in skeletal muscle two decades ago [5, 16], since 
then several isoforms were discovered, their localization described, and tissue 
distribution revealed. A study of Vassilopoulos and co-workers [33] proved the 
existence, among others, of a 32 kDa isoform of skeletal muscle triadin. They 
showed that unlike the other isoforms it localizes outside of the triad, in the 
longitudinal SR, and co-localizes with IP3R-s and mitochondria. The possibility 
was raised that the function of Trisk 32 could either be connected to Ca2+ release 
via IP3R, to the maintenance of sarcomere structure during contraction, or to the 
Ca2+-storage in the mitochondria. 
To clarify whether or not Trisk 32 plays any role in the regulation of IP3R, 
in a way analogous to the interaction between Trisk 95 and RyR, Trisk 32 was 
stably overexpressed in L6.G8 skeletal muscle myoblasts. The co-localization and 
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the physical association of Trisk 32 and IP3R was shown in transfected cells, and 
their functional association was also demonstrated. To stimulate the IP3 pathway 
either bradykinin or arginin-vasopressin was used. B2 bradykinin receptors were 
shown to be present on the L6 cell line [20] and their coupling to the IP3 pathway 
was also demonstrated in skeletal muscle [23]. Similarly, the presence of the IP3 
pathway-coupled V1 vasopressin receptors was described on the L6 cell line [29]. 
These results were confirmed here by showing the presence of these receptors 
using immunocytochemical labeling (see Online Resource 1A and 1B).  
It should be noted that the cells – L6.G8 myoblasts – used in these 
experiments represent the earliest stage of development. Previous studies have 
revealed that triadin expression parallels differentiation [33], that is, triadin 
expression is very low at the myoblast stage and increases as muscle cells 
differentiate. L6.G8 myoblasts should, therefore, provide an ideal system for 
studying Trisk 32 overexpression since any interaction between IP3Rs and triadins 
– if present – should be minimal in control cells, while in Trisk 32 overexpressing 
cells it should be close to maximal. 
The major finding of this work is that the overexpression of Trisk 32 
resulted in a significantly higher amplitude and maximal rate of rise of the Ca2+ 
transients evoked either by bradykinin (20 µM) or vasopressin (0.1 µM) via the 
IP3 pathway. This observation could have at least four independent but 
functionally related explanations. First, Trisk 32 overexpression might alter the 
coupling of the surface membrane receptors to the production of IP3, resulting in 
an increased amount of IP3 in transfected cells. Second, through direct protein-
protein interaction Trisk 32 could enhance the opening of IP3R in the presence of 
its agonist. Third, the overexpression of Trisk 32 could lead to an increased ER 
Ca2+ content and, consequently, to an increased amount of Ca2+ released from the 
store. Finally, Trisk 32 might modulate the coupling of the emptying of the 
intracellular Ca2+ store to surface membrane Ca2+ influx resulting in an increased 
SOCE. It should also be noted that an interaction, either direct coupling or via the 
released Ca2+ (Ca2+-induced Ca2+ release; CICR), to RyR-mediated Ca2+ release 
cannot, in theory, be ruled out. 
We present a number of observations against the first of the above 
mentioned possibilities. First of all, the stimulation of two independent pathways 
– B2 and V1 receptors – resulted in a similar enhancement of the Ca2+ signals, 
clearly arguing against this possibility, since it would require that Trisk 32 should 
at the same time interact with both B2 bradykinin and V1 vasopressin receptors. 
Although an effect on PLC cannot simply be ruled out using only the functional –
 Ca2+ transients – evidence, immunocytochemical staining does not favor a 
localization of the Trisk 32 protein that could easily be reconciled with such an 
interaction, that is, an interaction with a protein found in the plasma membrane. 
We also present evidence that IP3 receptor activation per se is unaltered if 
the receptors are stimulated directly. Namely, the extent of activation of IP3Rs by 
thimerosal – a widely used IP3R activator ([30, 32]; for review see eg. [8]) – was 
identical in control, in empty pcDNA3.1 vector transfected, and in Trisk 32-
overexpressing cells as assessed by the amplitude and rate of rise of the Ca2+ 
transients following thimerosal treatment. It should, however, be noted that 
thimerosal has been reported to interact with type I but not with type III IP3R [6]. 
The above mentioned observation could thus be interpreted as an indication that in 
Trisk 32-overexpressing cells the conductance of IP3R is unaltered (note that 
independent evidence suggests that the content of the Ca2+ store was indentical in 
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these cells, see below) or that the Trisk 32 protein interacts only with type III 
IP3R. 
Importantly though, both functional and co-localization/co-
immunoprecipitation experiments are strongly in favor of a direct interaction 
between IP3R (possibly type III, see above) and Trisk 32. In this framework the 
presence and direct protein-protein interaction of Trisk 32 and the calcium 
channel would result in an increased amount of Ca2+ released from the ER. This 
was observed as an enhancement of the Ca2+ transients in the absence of external 
Ca2+. Note that in the presence of normal external Ca2+ the difference between 
transfected and non-transfected cells was even greater suggesting that the 
increased release and, therefore, the more pronounced depletion of Ca2+ in the ER 
resulted in an enhanced SOCE in Trisk 32 overexpressing cells. 
On the other hand, we provide evidence that the overexpression of 
Trisk 32 does not directly affect the mechanism of SOCE. To examine the 
possibility, the ER Ca2+ store was emptied by the application of the SERCA pump 
inhibitor thapsigargin in a Ca2+-free extracellular milieu, and then the re-addition 
of extracellular Ca2+ triggered the Ca2+-influx via the plasma-membrane [4]. 
Neither the amplitude, nor the maximal rate of rise of SOCE differed significantly 
in Trisk 32-overexpressing cells, as compared to control. However, as examined 
by Western-blot, the expression of TRPC1 – an important store-operated Ca2+ 
channel of the plasma-membrane [2, 3] – did not change in Trisk 32-
overexpressing cells, but the expression of STIM1 – the Ca2+ sensor of the ER 
[15, 25] – decreased significantly, despite the fact that its functional consequence 
was not detectable by the [Ca2+]i measurements (similar observation – decreased 
STIM1 expression with no parallel decrease in SOCE – was made on transfected 
C2C12 cells, too, [21]). Taken together, these results suggest that the main effect 
of Trisk 32 overexpression is not the alteration of the functionality of SOCE. 
In addition, these experiments provided means to tackle the filling of the 
intracellular Ca2+ stores. By measuring the amplitude and the integral of the 
thapsigargin-evoked Ca2+ transients and finding no significant difference in either 
when comparing control and transfected cells, suggest that the overexpression of 
Trisk 32 does not affect the Ca2+ content of the ER Ca2+ store. 
The 95 kDa isoform of triadin is known to regulate Ca2+ release via RyRs 
[9, 24]. To exclude the possibility that such an interaction from Trisk 32 or an 
enhanced CICR was responsible for the increased Ca2+ transients evoked by 
bradykinin or AVP, functional [Ca2+]i measurements were performed. Neither the 
application of 30 mM caffeine an agonist of RyR alone nor the presence of 10 µM 
ryanodine when bradykinin was applied initiated significant alterations in the Ca2+ 
signals. That is, the caffeine-evoked responses were essentially identical in control 
and transfected cells, while the amplitude of the bradykinin-evoked transients 
were not significantly lower with or without ryanodine, and, furthermore, they did 
not decrease to the level of control cells. These results indicate that the effects of 
the overexpression of Trisk 32 cannot be accounted for solely by an altered RyR 
function. It should, nevertheless, be noted that the slight reduction in the 
amplitude of the bradykinin-evoked Ca2+ transients in the presence of ryanodine 
suggests that CICR might be involved, albeit to a lesser extent, in the Ca2+ signals 
of L6 cells. 
In conclusion, the significant enhancement of the bradykinin- and 
vasopressin-evoked Ca2+ transients in Trisk 32 overexpressing cells is due to the 
increased Ca2+ release from the intracellular Ca2+ store resulting from a direct 
interaction of Trisk 32 and IP3R. 
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Figure Captions 
 
Fig. 1 
Overexpression of Trisk 32 in L6.G8 myoblasts. (A) Immunocytochemical staining of control and 
Trisk 32-transfected L6 cell cultures demonstrating the presence of Trisk 32 protein. The rat 
isoform was expressed from the plasmid used for stable transfection. Images were recorded from 
2 µm thick optical slices. Original magnification was 40×. (B) mRNA expression of Trisk 32 was 
detected by RT-PCR. Samples from control and transfected cells were compared. GAPDH was 
used as a control. (C) Western-blot analysis of Trisk 32 was performed to analyze the 
overexpression at protein level. (SR – rat light SR fraction; C – control L6 myoblasts; Ø – L6 
myoblasts transfected with empty pcDNA 3.1 vector; T32 – Trisk 32-overexpressing L6 
myoblasts)  
 
Fig. 2 
Examination of the functional association of Trisk 32 and IP3R. Confocal microscopy line-scan 
images and time courses of Fluo-4 fluorescence in control myoblasts (A), in myoblasts transfected 
with empty pcDNA 3.1 vector (B), and in Trisk 32-overexpressing myoblasts (C) showing the 
transients evoked by the application of 0.1 µM AVP in the absence of [Ca2+]e. Time courses were 
calculated from the lines marked by arrows on the line-scan images. Horizontal and vertical 
calibrations are the same for all traces in A, B and C. (D) Pooled data from the amplitude of the 
transients. (E) Effect of pre-treatment with 50 µM Xestospongin C for 1 h on the amplitude of 
0.1 µM AVP-induced Ca2+ transients in Trisk 32-overexpressing cells in the absence of [Ca2+]e. 
[Ca2+]i of the cells was measured with PTI Delta Scan system. Here, and in all subsequent figures 
asterisks (*) mark significant difference between control and Trisk 32 overexpressing cells and 
data represent mean ± standard error (SE) of the mean. Paragraph signs (§) mark significant 
difference compared to empty pcDNA 3.1 vector transfected cells (shown as Ø-vector in the bar 
graphs). Hashmark (#) indicates significant (p < 0.05) change between data obtained in the 
absence and presence of Xestospongin C. Numbers in parentheses give the number of cells 
measured.  
 
Fig. 3 
(A) Representative records of 20 µM bradykinin-evoked Ca2+ transients in the presence (upper 
panels) and absence (bottom panels) of extracellular calcium ([Ca2+]e) in control and Trisk 32-
overexpressing cells. Pooled data for the amplitude (B) and the maximal rate of rise (C) of the 
transients. Hashmark (#) indicates significant (p < 0.05) change between data obtained in the 
absence and presence of [Ca2+]e. Numbers in parentheses give the number of cells measured. 
 
Fig. 4 
Direct activation of IP3Rs with thimerosal. (A) Representative records of Ca2+ transients evoked by 
50 µM thimerosal measured in the absence of extracellular calcium in control, empty pcDNA3.1 
vector transfected and Trisk 32-overexpressing cells. Pooled data for the amplitude (B) and the 
maximal rate of rise (C) of the transients. Numbers in parentheses give the number of cells 
studied. 
Fig. 5 
The effect of Trisk 32 overexpression on store-operated Ca2+-entry (SOCE). By using Western-
blot analysis, the expression of STIM1 (A) and TRPC1 (B) proteins were shown in control (C) and 
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Trisk 32-overexpressing (T32) cells. 100-100 µg protein samples were used in each lane for the 
Western-blot experiments. (C) Quantitative analysis of Western-blot results (mean ± SE) obtained 
from control and transfected myoblasts. (D) Changes in [Ca2+]i demonstrating SOCE were 
recorded following the re-establishment of the normal (1.8 mM) [Ca2+]e in control and in Trisk 32-
overexpressing cells. The internal calcium-stores were emptied by 2 µM thapsigargin (TG) in the 
absence of [Ca2+]e. Representative records of 4-4 independent cultures. Mean values of the 
amplitude (E) and the maximal rate of rise (F) of SOCE after the re-administration of external 
calcium. (G) Integral and amplitude of thapsigargin evoked Ca2+ transients. Numbers in 
parentheses indicate the number of cells measured.  
 
Fig. 6 
Functional effects of Trisk 32 overexpression on Ca2+-induced Ca2+-release (CICR) via ryanodine 
receptors (RyR). (A) Representative records of calcium transients evoked by the RyR agonist 
30 mM caffeine in control and in Trisk 32-overexpressing L6 cells. (B) Amplitudes of caffeine-
evoked Ca2+ transients in both cell types. (C) Western-blot analysis showing the expression of 
RyR in rat skeletal muscle quadriceps microsome, used as positive control (Lane 1), control L6 
cells (Lane 2) and Trisk 32-overexpressing L6 cells (Lane 3). (D) Amplitudes of 20 µM 
bradykinin-evoked Ca2+ transients in the absence and presence of the RyR antagonist 10 µM 
ryanodine, in Trisk 32-overexpressing myoblasts, at normal 1.8 mM [Ca2+]e. Numbers in 
parentheses indicate the number of cells measured.  
 
